I agree with what you're saying as it relates to other companies, but as you know, this is a very small company that has little to report on other than the NASH results which could be tied up in an NDA if they're in negotiations. I'm not expecting any PRs on the BLA until it's filed, no news on the Brazil trials until they hit their interim points, and nothing on the mTNBC results until there's some movement worthy of an announcement. Additionally, "if" there is a potential partnership under negotiation, it could be for multiple indications like NASH and cancer. I can't think of any other reason for this silent period. I think it's too far of a stretch to think lawyers are telling them to stay silent and not communicate with their shareholders for fear of upsetting the SEC or FDA. If that was true, then at what point do the lawyers tell them they can resume communications? That just doesn't make any sense to me. Companies can't survive or attract investors like that.
Quote:my point on the NDA is they usually don't freeze all communication, such as PRs regarding their products or services
4
CytoDyn Inc (CYDY) Stock Research Links
My comments are just my opinions and should NOT be taken as investment advice.
